Molecular analysis of a compound heterozygote for hypoprothrombinemia and dysprothrombinemia (-G 7248/7249 and ARG 340 TRP)

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 6, 1997, Pages 337-343

  Tamary, H ^d,e   Surrey, S ^b,c   Augustine, J ^a   Shalmon, L ^d,e   Schwartz, E ^b,c   Rappaport, E F ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d RABIN MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dysprothrombinemia; Hypoprothrombinemia; Molecular analysis

Indexed keywords

ARGININE; DNA; PROTHROMBIN; THROMBIN; TRYPTOPHAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; COMPUTER MODEL; DNA SEQUENCE; DYSPROTHROMBINEMIA; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; HETEROZYGOTE; HUMAN; HYPOPROTHROMBINEMIA; PRIORITY JOURNAL;

EID: 0030809781     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199709000-00003     Document Type: Article

References (42)

1. Jackson CM. The biochemistry of prothrombin activation. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1987; 165.
2. Mann KG, Elion J. Prothrombin. In: Schmidt RM, ed. CRC Handbook Series in Clinical Laboratory Science (sec. 1). Cleveland: CRC, 1980; 15-31.
3. Royle NJ, Irwin DM, Loschinsky ML, MacGillivary RTA, Hamerton JL. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Molec Genet 1987; 13: 285-292.
4. Degen SJF, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987; 26: 6165-6177.
5. Bloom AL. Inherited disorders of blood coagulation. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis, Edinburgh: Churchill Livingstone, 1987; 393.
6. Board PG, Shaw DC. Determination of the amino acid substitution in human prothrombin type 3 (157 Glu → Lys) and the localization of a third thrombin cleavage site. Br J Haematol 1983; 54: 245-254.
7. Rabiet MJ, Jandort-Perrus M, Boissel JP, Elion J, Josso F. Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin. Blood 1984; 63: 927-934.
8. Ruiz-Saez A, Luengo J, Rodriquez A, Ojeda A, Gomez O, Acurero Z. Prothrombin Perija: a new congenital dysprothrombinemia in an Indian family. Thromb Res 1986; 44: 587-598.
9. Rocha E, Paramo JA, Bascones C, Fisac RP, Cuesta B, Fernandez J. Prothrombin Segovia: a new congenital abnormality of prothrombin. Scand J Haematol 1986; 36: 444-449.
10. Miyata T, Morita T, Inomoto T, Kawauchi S, Shirakami A, Iwanaga S. Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima. Biochemistry 1987; 26: 1117-1122.
11. Diuguid D, Rabiet MJ, Furie B. Molecular defects of factor IX Chicago-2 (arg145 → his) and prothrombin Madrid (arg271 → cys): arginine mutations that preclude zymogen activation. Blood 1989; 74: 193-200.
12. Rabiet MJ, Furie BC, Furi B. Molecular defect of prothrombin Barcelona, substitution of cysteine for arginine at residue 273. J Biol Chem 1986; 261: 25045-25048.
13. Owen CA, Henriksen RA, McDuffie FC, Mann KG. Prothrombin Quick. Mayo Clin Proc 1978; 53: 29-33.
14. Henriksen RA, Mann KG: Identification of the primary structural defect in dysthrombin Quick I: substitution of cysteine for arginine-382. Biochemistry 1988; 27: 9160-9165.
15. Henriksen RA, Mann KG. Substitution of valine for glycine-558 in congentital dysthrombin Quick II alters primary substrate specificity. Biochemistry 1988; 28: 2078-2082.
16. Iwahana HI, Yoshimoto K, Shigekiyo T, Shirakami A, Saito S, Itakura M. Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia. Am J Hum Genet 1992; 51: 1386-1395.
17. Morishta E, Saito M, Kumabadhiri I, Asakur H, Matasuda T, Yamaguchi K. Prothrombin Himi: a compound heterozygous for two dysfunctional prothrombin molecules (Met-337 → Thr and Arg-388 → His). Blood 1992; 80: 2275-2280.
18. James HL, Kim DJ, Zhemg DQ, Girolami A. Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site. Blood Coag Fibrinol 1994; 5: 841-844.
19. Poort SR, Miciels JJ, Reitsma PH, Bertina RM. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 1994; 72: 819-824.
20. Degen SJF, McDowell SA, Spark LM, Scharrer I. Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala. Thromb Haemost 1995; 73: 203-209.
21. Miyata T, Zheng YZ, Kato A, Kato H. A point mutation (Arg271 → Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability. Br J Haemotol 1995; 90: 688-692.
22. O'Marciagh AS, Nichols W, Hassinger NL, Mullins JD, Mallogh AA, Gilchrist GS, Owen WG. Genetic analysis and functional characterization of prothrombin Corpus Christ (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia. Blood 1996; 88: 2611-2616.
23. Gill FM, Shapiro SS, Schwartz E. Severe congenital hypoprothrombinemia. J Pediatr 1978; 93: 264-266.
24. Poncz M, Solowiejczyk D, Harpel B, Morey Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of β-like globin genes. Hemoglobin 1982; 6: 27-36.
25. McBride LK, Koepf SM, Gibbs RA, Salser W, Mayrand PE, Hunkapiller MW, et al. Automated DNA sequencing methods involving the polymerase chain reaction. Clin Chem 1989; 35: 2196-2201.
26. Tamary H, Kirschmann H, Shalmon L, Zaizov R, Schwartz E, Rappaport EF. Automated fluorescent-based analysis of amplified genomic DNA for rapid detection of point mutations. Am J Hematol 1994; 46: 127-133.
27. Stubbs MT, Oschkinat H, Mayer R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. Eur J Biochem 1992; 206: 187-195.
28. Simmerling C, Elber R, Zhanj J. Moil View - a program for visualization of structure and dynamics of biomolecules and STO - a program for computation of stochastic paths. In: Pullman E, ed. Modeling of Bimolecular Structures and Mechanisms. The Netherlands: Kluwer Academic Publications, 1995; 241-265.
29. Degan SJF, Davie EW. The prothrombin gene and serine proteinase evolution. Ann NY Acad Sci 1986; 485: 66-72.
30. Iwahana H, Mizusawa N, Hukura M. Nco I RFLP in the human prothrombin (F2) gene. Nucleic Acid Res 1991; 19: 4309.
31. Iwahana H, Yoshimoto K, Itakura M. Highly polymorphic region of the human prothrombin (F2) gene. Hum Genet 1992; 89: 123-124.
32. Krawczak M, Cooper D. Gene deletions causing human genetic disease: mechanism of mutagenesis and the role of the local DNA sequence environment. Hum Genet 1991; 86: 425-441.
33. Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 1984; 36: 131-138.
34. Thompson AR. Molecular biology of the hemophilias. Prog Hemostas Thromb 1991; 10: 175-214.
35. Chen SH, Zhang M, Lovrien EW, Scott CR, Thompson AR. CG dinucleotide transition in the factor IX gene accounts for about half of the point mutations in hemophilia B patients: a Seattle series. Hum Genet 1991; 87: 177-182.
36. Hopp TP, Woods KR. Prediction of protein antigenic determinants for amino acid sequences. Proc Natl Acad Sci USA 1981; 78: 3824-3828.
37. Furie B, Bing DH, Feldman RJ, Robinson DJ, Burnier J, Furie BC. Computer-generated models of blood coagulation factor Xa, factor IXa and thrombin based upon structural homology with other serine proteases. J Biol Chem 1982; 257: 3875-3882.
38. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, et al. The structure of a complex of recombinant hirudin and human α-thrombin. Sciences 1990; 249: 277-280.
39. Grutter MG, Priestle JP, Rahuel J, Grossenbacher H, Bode W, Hofsteenge J, et al. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J 1990; 9: 2361-2365.
40. Goughlin SR, Vu TKH, Hung DT, Wheaton VI. Characterization of a functional thrombin receptor. J Clin Invest 1992; 89: 351-355.
41. Rydel TJ, Tulinsky A, Bode W, Huber R. Refined structure of the hirudin-thrombin complex. J Mol Biol 1991; 221: 583-601.
42. Schulz GE, Schrimer RH. Principles of protein structure. New York, Berlin: Springer Verlag, 1979; 36-42.